SEARCH · Engineering Papers
Results for “PHOSPHORYLATION”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Catalytic-site design for inverse heavy-enzyme isotope effects in human purine nucleoside phosphoryl
Explore the source record for details and available documents.
Structural basis of the phosphorylation-independent recognition of cyclin D1 by the SCFFBXO31 ubiquitin ligase
Explore the source record for details and available documents.
An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a Unique Mechanism for Phosphoepitope Recognition
Abstract not provided
A Mechanism of Global Shape-dependent Recognition and Phosphorylation of Filamin by Protein Kinase A
Abstract not provided
Modifications to a common phosphorylation network provide individualized control in caspases
Abstract not provided
The Global Phosphoproteome of Chlamydomonas reinhardtii Reveals Complex Organellar Phosphorylation in the Flagella and Thylakoid Membrane
Explore the source record for details and available documents.
Regulation of Protein Interactions by M ps O ne B inder (MOB1) Phosphorylation
Abstract not provided
PhosPhAt: the Arabidopsis thaliana phosphorylation site database. An update
Explore the source record for details and available documents.
Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening
Tyrosyl DNA-phosphodiesterase I (TDP1) repairs type IB topoisomerase (TOP1) cleavage complexes generated by TOP1 inhibitors commonly used as anticancer agents. TDP1 also removes DNA 3' end blocking lesions generated by chain-terminating nucleosides and alkylating agents, and base oxidation both in the nuclear and mitochondrial genomes. Combination therapy with TDP1 inhibitors is proposed to synergize with topoisomerase targeting drugs to enhance selectivity against cancer cells exhibiting deficiencies in parallel DNA repair pathways. A crystallographic fragment screening campaign against the catalytic domain of TDP1 was conducted to identify new lead compounds. Crystal structures revealed two fragments that bind to the TDP1 active site and exhibit inhibitory activity against TDP1. These fragments occupy a similar position in the TDP1 active site as seen in prior crystal structures of TDP1 with bound vanadate, a transition state mimic. Using structural insights into fragment binding, several fragment derivatives have been prepared and evaluated in biochemical assays. These results demonstrate that fragment-based methods can be a highly feasible approach toward the discovery of small-molecule chemical scaffolds to target TDP1, and for the first time, we provide co-crystal structures of small molecule inhibitors bound to TDP1, which could serve for the rational development of medicinal TDP1 inhibitors.
How an mRNA capping enzyme reads distinct RNA polymerase II and Spt5 CTD phosphorylation codes
Abstract not provided
Structural determination of the phosphorylation domain of the ryanodine receptor
Abstract not provided